International Journal of Molecular Medical Science, 2024, Vol.14, No.2, 144-152 http://medscipublisher.com/index.php/ijmms 152 Ross S.A., Tildesley H.D., and Ashkenas J., 2011, Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes, Current Medical Research and Opinion, 27(sup3): 13-20. https://doi.org/10.1185/03007995.2011.621416 PMid:21942467 Schaepelynck P., Darmon P., Molines L., Jannot-Lamotte M.F., Treglia C., and Raccah D., 2011, Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps, Diabetes and Metabolism, 37: S85-S93. https://doi.org/10.1016/S1262-3636(11)70972-7 PMid:22208717 Schweiger S.D., 2023, Recent advances in immune-based therapies for type 1 diabetes, Hormone Research in Paediatrics, 96(6): 631-645. https://doi.org/10.1159/000524866 PMid:35533645 Sibiya N., Mbatha B., Ngubane P., and Khathi A., 2023, Celebrating a century of insulin discovery: a critical appraisal of the emerging alternative insulin delivery systems, Current Drug Delivery, 20(6): 656-668. https://doi.org/10.2174/1567201819666220531101203 PMid:35642116 Sorli C., and Heile M.K., 2014, Identifying and meeting the challenges of insulin therapy in type 2 diabetes, Journal of Multidisciplinary Healthcare, 267-282. https://doi.org/10.2147/JMDH.S64084 PMid:25061317 PMCid:PMC4086769 Soukup T., Hull L., Smith E.L., Healey A., Bakolis I., Amiel S.A., Sevdalis N., and Group P., 2019, Effectiveness-implementation hybrid type 2 trial evaluating two psychoeducational programmes for severe hypoglycaemia in type 1 diabetes: implementation study protocol, BMJ Open, 9(11): e030370. https://doi.org/10.1136/bmjopen-2019-030370 PMid:31727650 PMCid:PMC6886982 Stabler C.L., Li Y., Stewart J.M., and Keselowsky B.G., 2019, Engineering immunomodulatory biomaterials for type 1 diabetes, Nature Reviews Materials, 4(6): 429-450. https://doi.org/10.1038/s41578-019-0112-5 PMid:32617176 PMCid:PMC7332200 Tatovic D., and Dayan C.M., 2021, Replacing insulin with immunotherapy: time for a paradigm change in type 1 diabetes, Diabetic Medicine, 38(12): e14696. https://doi.org/10.1111/dme.14696 PMid:34555209 Timmons J.G., Littlejohn L., Boyle J.G., and Petrie J.R., 2022, Recent developments in adjunct therapies for type 1 diabetes, Expert Opinion on Investigational Drugs, 31(12): 1311-1320. https://doi.org/10.1080/13543784.2022.2159806 PMid:36655950 Van Belle T.L., Coppieters K.T., and Von Herrath M.G., 2011, Type 1 diabetes: etiology, immunology, and therapeutic strategies, Physiological Reviews, 91(1): 79-118. https://doi.org/10.1152/physrev.00003.2010 PMid:21248163 van den Boom L., Auzanneau M., Woelfle J., Sindichakis M., Herbst A., Meraner D., Hake K., Klinkert C., Gohlke B., and Holl R.W., 2023, Use of continuous glucose monitoring in pump therapy sensor augmented pump or automated insulin delivery in different age groups (0.5 to< 26 years) with type 1 diabetes from 2018 to 2021: analysis of the German/Austrian/Swiss/Luxemburg DPV registry, Journal of Diabetes Science and Technology, 19322968231156601. https://doi.org/10.1177/19322968231156601 PMid:36840616 Warshauer J.T., Bluestone J.A., and Anderson M.S., 2020, New frontiers in the treatment of type 1 diabetes, Cell Metabolism, 31(1): 46-61. https://doi.org/10.1016/j.cmet.2019.11.017 PMid:31839487 PMCid:PMC6986815 Yoo J.H., and Kim J.H., 2023, Advances in continuous glucose monitoring and integrated devices for management of diabetes with insulin-based therapy: improvement in glycemic control, Diabetes and Metabolism Journal, 47(1): 27-41. https://doi.org/10.4093/dmj.2022.0271 PMid:36635028 PMCid:PMC9925143 Disclaimer/Publisher's Note The statements, opinions, and data contained in all publications are solely those of the individual authors and contributors and do not represent the views of the publishing house and/or its editors. The publisher and/or its editors disclaim all responsibility for any harm or damage to persons or property that may result from the application of ideas, methods, instructions, or products discussed in the content. Publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==